Cytosorbents
CTSO
#10674
Rank
NZ$36.23 M
Marketcap
NZ$0.58
Share price
1.61%
Change (1 day)
-64.15%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -NZ$21.37 Million

According to Cytosorbents's latest financial reports the company's current earnings are NZ$37.2 Million. In 2025 the company made an earning of -NZ$14.55 Million, an increase over its 2024 earnings that were of -NZ$38.43 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$21.37 Million46.94%
2025 -NZ$14.55 Million-62.16%
2024 -NZ$38.43 Million-22.49%
2023 -NZ$49.58 Million-13.52%
2022 -NZ$57.34 Million34.04%
2021 -NZ$42.78 Million182.17%
2020 -NZ$15.16 Million-55.97%
2019 -NZ$34.43 Million14.17%
2018 -NZ$30.15 Million95.14%
2017 -NZ$15.46 Million-22.32%
2016 -NZ$19.89 Million39.1%
2015 -NZ$14.3 Million-12.89%
2014 -NZ$16.42 Million89%
2013 -NZ$8.69 Million26.65%
2012 -NZ$6.86 Million-26.02%
2011 -NZ$9.27 Million-288.45%
2010 NZ$4.91 M-4.17%
2009 NZ$5.13 M-287.19%
2008 -NZ$2.75 Million-47.12%
2007 -NZ$5.19 Million41.78%
2006 -NZ$3.66 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
NZ$6.32 B-30,646.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$1.31 B-6,447.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
NZ$93.85 M-553.11%๐Ÿ‡บ๐Ÿ‡ธ USA